BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 16951733)

  • 1. The need for speed: an update on methamphetamine addiction.
    Barr AM; Panenka WJ; MacEwan GW; Thornton AE; Lang DJ; Honer WG; Lecomte T
    J Psychiatry Neurosci; 2006 Sep; 31(5):301-13. PubMed ID: 16951733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Increasing prevalence of amphetamine--and methamphetamine-induced psychosis].
    Härtel-Petri R; Rodler R; Schmeisser U; Steinmann J; Wolfersdorf M
    Psychiatr Prax; 2005 Jan; 32(1):13-7. PubMed ID: 15633070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methamphetamine induced neurotoxic diseases, molecular mechanism, and current treatment strategies.
    Shrestha P; Katila N; Lee S; Seo JH; Jeong JH; Yook S
    Biomed Pharmacother; 2022 Oct; 154():113591. PubMed ID: 36007276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An exploratory analysis of neurocognition in methamphetamine-induced psychotic disorder and paranoid schizophrenia.
    Jacobs E; Fujii D; Schiffman J; Bello I
    Cogn Behav Neurol; 2008 Jun; 21(2):98-103. PubMed ID: 18541986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotic symptoms in methamphetamine psychotic in-patients.
    Srisurapanont M; Ali R; Marsden J; Sunga A; Wada K; Monteiro M
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):347-52. PubMed ID: 14604449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings.
    Panenka WJ; Procyshyn RM; Lecomte T; MacEwan GW; Flynn SW; Honer WG; Barr AM
    Drug Alcohol Depend; 2013 May; 129(3):167-79. PubMed ID: 23273775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BDNF-Deficient Mice Show Reduced Psychosis-Related Behaviors Following Chronic Methamphetamine.
    Manning EE; Halberstadt AL; van den Buuse M
    Int J Neuropsychopharmacol; 2016 Apr; 19(4):. PubMed ID: 26453694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of binge-dosed methamphetamine-induced neurotoxicity and neuroinflammation.
    McConnell SE; O'Banion MK; Cory-Slechta DA; Olschowka JA; Opanashuk LA
    Neurotoxicology; 2015 Sep; 50():131-41. PubMed ID: 26283213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trace amine-associated receptor 1 regulation of methamphetamine-induced neurotoxicity.
    Miner NB; Elmore JS; Baumann MH; Phillips TJ; Janowsky A
    Neurotoxicology; 2017 Dec; 63():57-69. PubMed ID: 28919515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A commentary on the effects of methamphetamine and the status of methamphetamine abuse among youths in South Korea, Japan, and China.
    Kwon NJ; Han E
    Forensic Sci Int; 2018 May; 286():81-85. PubMed ID: 29567545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of methamphetamine abuse in Missouri.
    Topolski JM
    Mo Med; 2007; 104(1):82-8. PubMed ID: 17410832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting severity of positive and negative symptoms of psychosis in a polysubstance using population with psychostimulant dependence.
    Willi TS; Honer WG; Thornton AE; Gicas K; Procyshyn RM; Vila-Rodriguez F; Panenka WJ; Aleksic A; Leonova O; Jones AA; MacEwan GW; Barr AM
    Psychiatry Res; 2016 Jun; 240():336-342. PubMed ID: 27138828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methamphetamine, neurotransmitters and neurodevelopment.
    Čechová B; Šlamberová R
    Physiol Res; 2021 Dec; 70(S3):S301-S315. PubMed ID: 35099249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health outcomes associated with methamphetamine use among young people: a systematic review.
    Marshall BD; Werb D
    Addiction; 2010 Jun; 105(6):991-1002. PubMed ID: 20659059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid hormone treatment alleviates the impairments of neurogenesis, mitochondrial biogenesis and memory performance induced by methamphetamine.
    Seyedhosseini Tamijani SM; Beirami E; Ahmadiani A; Dargahi L
    Neurotoxicology; 2019 Sep; 74():7-18. PubMed ID: 31075280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal insulin treatment restores cognitive deficits and insulin signaling impairment induced by repeated methamphetamine exposure.
    Beirami E; Oryan S; Seyedhosseini Tamijani SM; Ahmadiani A; Dargahi L
    J Cell Biochem; 2018 Feb; 119(2):2345-2355. PubMed ID: 28884876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of methamphetamine psychosis: history of ADHD-relevant childhood behaviors and drug exposure.
    Salo R; Fassbender C; Iosif AM; Ursu S; Leamon MH; Carter C
    Psychiatry Res; 2013 Dec; 210(2):529-35. PubMed ID: 23896355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hostility among methamphetamine users experiencing psychotic symptoms.
    McKetin R; McLaren J; Lubman DI; Hides L
    Am J Addict; 2008; 17(3):235-40. PubMed ID: 18464001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In Germany difficult to come by. Crystal meth: "definitely one of the most dangerous drugs in the world"].
    Oberhofer E
    MMW Fortschr Med; 2014 Aug; 156(14):18-9. PubMed ID: 25195388
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term cognitive, emotional and neurogenic alterations induced by alcohol and methamphetamine exposure in adolescent rats.
    Loxton D; Canales JJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Mar; 74():1-8. PubMed ID: 27865801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.